Oncology
About Oncology
Oncology is the medical speciality that deals with the research, diagnosis and treatment of cancer. Cancer occurs when cells in the body grow uncontrollably, form tumours or spread to other parts of the body. With over 100 different types of cancer, oncology encompasses numerous specialist areas such as medical oncology, surgical oncology and radiation oncology.
At Oncoscience GmbH, we focus on precision medicine in order to investigate new research approaches for the treatment of common and rare types of cancer. Our focus is on research into individualised approaches based on genetic and molecular findings. Our aim is to advance research in the field of personalised treatment strategies in order to further develop individual therapy options.
We pay particular attention to cancers that are difficult to diagnose or treat. Our research focuses on deepening the understanding of such diseases and investigating innovative scientific concepts.
About Rare Diseases
Rare diseases only affect a small proportion of the population – often less than 1 in 2,000 people. These include genetic, neurological or metabolic diseases as well as rare types of cancer. Although they are rare when considered individually, millions of people worldwide are affected by such diseases.
For those affected, access to precise diagnoses and suitable treatments is often a major challenge. Due to the limited patient populations, these diseases are often neglected in medical research.
Oncoscience GmbH is dedicated to the research and development of new approaches to better understand rare diseases and to gain scientific knowledge for possible treatment options. Our expertise in genetics and personalised medicine enables us to research new scientific concepts that can be used to develop innovative treatment approaches. The aim is to gain new insights through research and cooperation with scientific partners that can contribute to the development of innovative therapeutic approaches in the long term.
About Orphan Drugs
Orphan drugs are medicines that are specially developed to treat rare diseases. Such diseases are often considered economically unviable for large-scale drug development. To compensate for this, health authorities worldwide promote the development of such drugs through measures such as accelerated authorisation procedures, market exclusivity and tax incentives.
Oncoscience GmbH is active in the field of orphan drugs with a focus on rare cancers and rare diseases. Through innovative research approaches, we contribute to gaining scientific knowledge for potential new treatment approaches. With a clear focus on the genetic and molecular causes of these diseases, we rely on research and collaborations to further develop scientific understanding and potential treatment options.